Dock2 participates in bone marrow lympho-hematopoiesis

被引:14
|
作者
Kikuchi, Tomoko [2 ]
Kubonishi, Shiro [2 ]
Shibakura, Misako [2 ]
Namba, Noriko [2 ]
Matsui, Toshimitsu [1 ]
Fukui, Yoshinori [3 ]
Tanimoto, Mitsune [2 ]
Katayama, Yoshio [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Med, Cho Ku, Kobe, Hyogo 6500017, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 812, Japan
关键词
hematopoietic stem/progenitor cells; Dock2; CXCR4; CXCL12;
D O I
10.1016/j.bbrc.2007.12.093
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hernatopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hernatopoietic compartment, including hernatopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although alpha 4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hernatopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 50 条
  • [1] ANTIGEN EXPRESSION IN LYMPHO-HEMATOPOIESIS
    MINOWADA, J
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 417 - 417
  • [2] Cellular Niches for Hematopoietic Stem Cells and Lympho-Hematopoiesis in Bone Marrow During Homeostasis and Blood Cancers
    Omatsu, Yoshiki
    Higaki, Kei
    Nagasawa, Takashi
    BONE MARROW NICHE: MICROENVIRONMENTS CRITICAL FOR IMMUNE CELL DEVELOPMENT, 2021, 434 : 33 - 54
  • [3] Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?
    Anderson, KM
    Ondrey, F
    Harris, JE
    LEUKEMIA RESEARCH, 1999, 23 (01) : 51 - 56
  • [4] EVIDENCE FOR A ROLE OF THE INTEGRIN VLA-4 IN LYMPHO-HEMATOPOIESIS
    MIYAKE, K
    WEISSMAN, IL
    GREENBERGER, JS
    KINCADE, PW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03): : 599 - 607
  • [5] MONOCLONAL-ANTIBODIES TO PGP-1/CD44 BLOCK LYMPHO-HEMATOPOIESIS IN LONG-TERM BONE-MARROW CULTURES
    MIYAKE, K
    MEDINA, KL
    HAYASHI, S
    ONO, S
    HAMAOKA, T
    KINCADE, PW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02): : 477 - 488
  • [6] Lympho-hematopoiesis from differentiated human embryonic stem (ES) cells.
    Zhan, XC
    Dravid, G
    Hammond, H
    Ye, ZH
    Yang, XM
    Cheng, LZ
    BLOOD, 2002, 100 (11) : 292A - 292A
  • [7] Roring ahead with DOCK2
    Steele, Andrew J.
    BLOOD, 2018, 132 (02) : 115 - 116
  • [8] Dock2 in the development of inflammation and cancer
    Chen, Yayun
    Meng, Fan
    Wang, Bingyu
    He, Liangmei
    Liu, Yangbin
    Liu, Zhiping
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (06) : 915 - 922
  • [9] The CDM protein DOCK2 in lymphocyte migration
    Reif, K
    Cyster, JG
    TRENDS IN CELL BIOLOGY, 2002, 12 (08) : 368 - 373
  • [10] DOCK2 deficiency in one Iranian patient
    Alizadeh, Z.
    Mazinani, M. S.
    Nabavi, M.
    Fazlollahi, M.
    Houshmand, M.
    Pourpak, Z.
    ALLERGY, 2017, 72 : 588 - 589